Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. 
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Introduction
Recent research suggests that the wars in Afghanistan and Iraq, also known as Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF), pose substantial mental health challenges to U.S. military service members and mental health systems (Erbes, Westermeyer, Engdahl, & Johnsen, 2007; Hoge, Auchterlonie, & Milliken, 2006; Hoge et al., 2004; R. A. Rosenheck & Fontana, 2007; Seal, Bertenthal, Miner, Sen, & Marmar, 2007; Tanielian & Jaycox, 2008) . Post-traumatic stress disorder (PTSD), in particular, has risen steadily, with heavy combat typically being cited as a leading cause of PTSD (CDC, 1988; Helzer, Robins, & McEvoy, 1987; Hoge, et al., 2004; Kang, Natelson, Mahan, Lee, & Murphy, 2003; Prigerson, Maciejewski, & Rosenheck, 2002 ; The Iowa Persian Gulf Study Group, 1997) . This study examines the effects of the location and duration of OEF/OIF deployments (particularly to Afghanistan and Iraq) on the probability of being diagnosed with PTSD for still-active military personnel.
A recent comprehensive review of the literature by Rand found a wide range of PTSD rates among those serving in Iraq and Afghanistan, with estimates ranging from 4% to 45%, depending on the samples and how PTSD was measured (Tanielian & Jaycox, 2008) . Many studies used anonymous survey responses from convenience samples of Army soldiers who were deployed in either Iraq or Afghanistan from 2003 to 2005 (Erbes, et al., 2007; Grieger et al., 2006; Helzer, et al., 1987; Hoge, et al., 2004; Vasterling et al., 2006) . Some analyzed the mental health issues using postdeployment health assessment surveys collected by the Mental Health Advisory Team (MHAT), which measured PTSD by primary-care PTSD screening questions Shen, Arkes, & Pilgrim, 2009; U.S. Army, 2003 U.S. Army, , 2005 U.S. Army, , 2006a U.S. Army, , 2006b , while a few used actual medical records from the VA health care system.
With the Global War on Terrorism going into its 9 th year and with a planned surge of forces in Afghanistan being considered, it is critical to evaluate the prevalence of PTSD among the active duty population and how the deployment intensity in OEF/OIF affect the mental health readiness of the Armed Forces. While previous studies have provided important information on PTSD in the current operations, they have several shortcomings. First, the previous studies have been descriptive analyses except for a study analyzing UK solders and one focusing on the US Navy enlisted personnel (Rona et al., 2007; Shen, et al., 2009) . Second, most studies focus on just the Army and Marine Corps. Yet the rates of PTSD among those deployed in Iraq and Afghanistan could be different across services because of different types of assignments, and such differences are important to identify in evaluating total force readiness. Third, most studies used convenience samples on those returning from OEF/OIF, without a comparable control group of personnel who were not deployed under OEF/OIF. Thus, while these studies indicate the frequency of PTSD for those deployed under OEF/OIF, they cannot speak to the effect of being deployed under OEF/OIF relative to their risk of PTSD under other military operations. Fourth, studies using surveys often had to rely on screening questions (such as PCL-DSM IV), which are typically short and simple to administer but likely miss some cases of PTSD and misdiagnose PTSD in other cases (Kimerling et al., 2006; Ramchand, Karney, Osilla, Burns, & Caldarone, 2008) . Finally, previous studies focus on the effect of the deployment location (i.e, Iraq or Afghanistan) with little attention paid to the duration of deployment or the cumulative effect of multiple deployments on the PTSD occurrence. However, deployment duration and frequency are equally important deployment dimensions to consider when designing the optimal deployment strategy.
In this study, we address the shortcomings of the previous literature with a random sample The statistical methods we use were built upon our prior study that examined deployment intensity on the rate of PTSD among Navy personnel. (Shen, et al., 2009) This study differs in several important dimensions. First, while our prior study examined only sailors, in this study we compare the PTSD rates and deployment effects across all four services. Second, the prior study is based on the Post Deployment Health Assessment (PDHA) that were only filled by people who were deployed on GWOT missions, thus it cannot compare the rate of PTSD between those who were deployed and those who were sent on other missions. The current study addresses this shortcoming as discussed below. Third, the prior study can only capture PTSD cases right after the deployment based on four screening questions (since PHDA has to be filled out 30 days from the return of the deployment), while the current study allows us to have a much longer look-forward window to capture the PTSD cases and identify PTSD cases through clinical diagnoses. Lastly, it is important to keep in mind that in this study we focus on TRICARE eligible population (i.e., people who are still serving in the military during the study period, including ones with PTSD diagnoses), and our results give a sense of the mental health readiness among the still active personnel. We estimate our models separately for each service (Army, Air Force, Marines, and Navy) and separately for officers and enlisted personnel. We provide more details on the model specifications below. Lastly, we focus on the PTSD population and study their comorbidity distribution.
Data and Methods
Methods
Data and Sample.
We use a random sample of activity-duty personnel serving between For service characteristics, we include rank and military occupation specialty (MOS)
categories. Studies have shown that soldiers in combat divisions and those in medical service tend to have different rates of PTSD than non-combat specialties (Martin, 2007; Tanielian & Jaycox, 2008) .
We categorize military occupational specialty codes into the following categories: Combat arms To control for demographic characteristics, we include the following demographic information in the models: gender, race (with White as the reference group, African-American, Hispanic, Asian, and other races), marital status (single or married), and age. Lastly, we include year indicators to control for possible macro trends in the PTSD rate in the general active duty population. In the sensitivity analysis section, we also briefly discuss the results in which we take out the year indicators from the model, since later years is likely associated with increased deployment intensity.
Results
Characteristics of the Active Duty Enlisted Population. Table 1 presents the descriptive statistics of the enlisted sample by service branches. We focus our discussion on the deployment characteristics. The majority of the active duty personnel were not deployed under OEF/OIF: the percentages range from 61.5% in Air Force to 78% in Army. However, while not shown, this rate did vary by year as increasing numbers of Army and Marine Corps personnel were deployed under OEF/OIF in later years. Not surprisingly, the service with the highest share of its enlisted members sent to Iraq/Afghanistan is the Army (11.3%), followed by the Marine Corps (8.6%). The Navy and Air Force appear to serve a more supporting role, with 35% and 33%, respectively, of their enlisted population being sent on OEF/OIF missions other than to Iraq/Afghanistan. Among those deployed, large proportions of Army and Marine Corps personnel had been deployed more than 180 days in their most recent deployment prior to being included in the sample (58% and 48%, respectively), whereas 65% of deployed Air Force personnel had a tour length under 120 days.
The next set of summary statistics report the proportions of those ever deployed under OEF/OIF who were ever deployed to a given location since September 11, 2001. We categorize the past deployment location indicators into three mutually exclusive categories to allow for easier comparison (i.e., the three rows add up to 100% Characteristics of the Active Duty Officer Population. Table 2 presents the descriptive statistics of the officer sample by service branches. Similar to the enlisted population, the majority of the active duty officers were not deployed under OEF/OIF: the percentages range from 62.5% in Air Force to 74.7% in Army. Not surprisingly, the service with the highest share of its officer members sent to Iraq/Afghanistan is the Army (10.5%), followed by the Marine Corps (9.0%).
Similar to the enlisted population, the Navy and Air Force appear to serve a more supporting role, with 31.4% and 33%, respectively, of their officer population being sent on OEF/OIF missions other than to Iraq/Afghanistan. Among those deployed, almost half of Army and Marine Corps personnel had been deployed more than 180 days in their most recent deployment prior to being included in the sample, whereas 72% of deployed Air Force personnel had a tour length under 120 days.
PTSD Rate By Deployment Characteristics. Table 3 reports the proportion of the active duty population who were diagnosed with PTSD for each service, with the top panel presenting results of the enlisted population and the bottom panel presenting results of the officer population.
The first row presents the PTSD percentage for the entire active duty population, regardless of their deployment status, and ranges from 0.6% for the Air Force to 1.4% for the Army. The next set reports the PTSD rate by the last deployment location. People deployed to Iraq/Afghanistan had much higher rates of being diagnosed with PTSD compared to those not deployed under OEF or OIF (4.4% vs. 0.6% for the Army, 3.5% vs. 0.5% for the Marines, 6.5% vs. 0.5% for the Navy, and 1.3% vs. 0.6% for the Air Force; p<0.01 for statistical tests of all of these differences). Army and Marine Corps personnel deployed on other OEF/OIF missions also have higher rates of PTSD compared to those not deployed under OEF/OIF (3.8% for Army, 2.3% for Marines), but the opposite is the case for the Navy and Air Force. Among those deployed under OEF/OIF, the PTSD rate increases as the tour length increases. With the Army, for example, the proportion of enlisted personnel who were later diagnosed with PTSD is 2.9% among those with a short tour length (1-120 days), and the rate increases to 3. 5% in the medium length category (120-180 days) and to 4.8% for long tours (>180 days). We observe similar, but not as stark, patterns for the other three services.
The next set of statistics in the top panel of Table 3 reports the PTSD rate by whether a person was ever deployed to a given location. With the Army, the proportion of enlisted personnel ever deployed to Iraq/Afghanistan (but not on other OEF/OIF missions) who were diagnosed with PTSD is 3.5%. The number is slightly lower for those who were deployed on OEF/OIF missions other than to Iraq/Afghanistan (3.4%). The rate of PTSD is even higher (6.2%) for those who have been to Iraq/Afghanistan, as well as on other OEF/OIF missions. We observe similar pattern for the other three branches.
The rate of PTSD is much lower in the officer population (bottom panel of 
Multivariate Analysis of Deployment Intensity on PTSD Rates-Enlisted Population.
The raw proportions of personnel being diagnosed with PTSD shown in Table 3 provide a good comparison across services of the prevalence of PTSD based on types of deployments. We next report, in Table 4 , the logistic regression results that compare, across services, the effect of the OEF/OIF deployment on the risk of being diagnosed with PTSD relative to the risk enlisted personnel would have had in the more typical military missions around the world. We present the results in terms of odds ratios and focus only on the effects of deployment characteristics in Table 4 (the complete regression results for Model 1 are included in the Appendix). The top panel of Table   4 reports the main effect of the last deployment's location and duration. With the Army, the first row indicates that the odds of being diagnosed with PTSD is 3.96 times higher among those deployed to Iraq/Afghanistan compared to those not deployed under OEF/OIF (p<0.01). Being deployed on other OEF/OIF missions also increases the odds of PTSD by the same magnitude (OR=3.97, p<0.01). Model 1 also shows that the tour length matters. Compared to those who have a short tour length (<120 days), Army soldiers whose last deployment was between 120-180 days are 1.18 times more likely to get PTSD (p<0.01) and those whose last deployment was more than 180 days have an odds ratio of 1.62 (p<0.01). Similar adverse effects of longer tours are observed for the Navy and Air Force. For the Marine Corps, the duration effect only shows up if they have been deployed more than 180 days (OR=1.11, p<0.10). It is worth noting that the adverse effects of deployment location and length are present even after we control for MOS, and not surprisingly, those in combat arms specialty (the reference group) have the highest odds of being diagnosed with PTSD (see the Appendix).
For Model 2, presented in the lower panel of Table 3 , we add an interaction effect between the Iraq/Afghanistan location and the deployment duration variables to test whether long deployments exacerbate the effects of deployments to these two countries. For the Army, the 1.53
odds ratio on the "long" duration variable now indicates that those whose OEF/OIF deployment to locations other than Iraq/Afghanistan lasted more than 180 days are 1.53 times more likely to be diagnosed with PTSD than those whose last tour to those locations were under 120 days. The odds ratio on the Iraq/Afghanistan indicator now essentially compares the rate of PTSD between those deployed to Iraq/Afghanistan under 120 days and those not deployed to OEF/OIF missions. Even with a short tour, deployment to Iraq still results in an odds ratio of 3.70 (p<0.01). The same applies to the Marine Corps and Navy, but the Air Force still has a smaller effect of an Iraq/Afghanistan deployment.
The key variables are the last two rows of Model 2. Among soldiers whose last deployment was to Iraq/Afghanistan, those that lasted more than 180 days had a 1.15 times higher risk of being diagnosed with PTSD (p<0.10) compared to those with a short (less than 120-day) deployment, which is in addition to the main Iraq/Afghanistan effect of 3.96). For the Army, a medium-length deployment had no additional effect on the risk of being diagnosed with PTSD. We observe additive effects for the Navy (OR for the interactive terms on medium and long duration are 2.50 and 2.47, respectively, p<0.01), but not for the Marine Corps or Air Force.
Next, due to the potential lags in the onset and diagnosis of PTSD, we examine, in Model 3, how previous OEF/OIF deployments affect the probability of being diagnosed with PTSD. The results in Table 5 for the Navy (p<0.01 for all services) compared to those never sent on an OEF/OIF missions.
Model 4, in the bottom panel of In a sensitivity analysis, we address the empirical issue that the year variables could be highly correlated with the -OEF/OIF missions, thus causing multicollinearity and perhaps leading to an underestimation of the deployment effect on the risk of being diagnosed with PTSD. Thus we estimated models that excluded the year dummies, and the estimated effects of an Iraq/Afghanistan deployment on the risk of being diagnosed with PTSD were about 10-15 percent higher than our main models.
Multivariate Analysis of Deployment Intensity on PTSD Rates-Officer Population.
We next report, in Table 6 , the logistic regression results for officers, which is similar to what we have in Table 4 The second panel of Table 6 shows that there is little additive effect of deployment length on the location effect for officers, as long deployments to Iraq and Afghanistan carry similar odds of being diagnosed with PTSD as short deployment. However, it is important to note that for Navy officers, due to the small sample size, the interaction term's coefficient, though having an odds ratio of 16.32, also carries an extremely large standard error so that statistical inference is not possible.
We report the results from Model 3 in the last panel in Table 6 . The location effects are larger than those estimated in Model 1 (where we only capture the location of last deployment). The odds ratio of being diagnosed with PTSD for those ever deployed to Iraq/Afghanistan (but not other OEF/OIF locations) compared to those never deployed under OEF/OIF ranges from 2.04 times for the Marines to 3.66 times for the Navy. The odds of being diagnosed with PTSD by those who were deployed to Iraq/Afghanistan as well as on other OEF/OIF missions ranges from 1.27 for the Air Force (not statistically significant) to 5.16 for the Marine (p<0.01) compared to those never sent on an OEF/OIF mission. Due to the sample size, we cannot refine Model 3 further to incorporate the frequency of deployments to a given location as we did with the enlisted population.
Descriptive Analysis of PTSD Population Comorbidity Distribution. For the last
analysis of this report, we focus on just the PTSD population and provide a preliminary analysis of the mental health comorbidity in this population. Another way to examine the severity of the PTSD case is by looking at number of mental health comorbidity in addition to PTSD (second panel of Table 7 ). Among the inpatient PTSD population, over 85 percent has at least one comorbidity with a substantial minority (14-17 percent, depending on the service) having two or more mental health illnesses in addition to PTSD. Among the outpatient PTSD population, between 45 percent (Navy) to 54 percent (Army) have a simple case of PTSD without any additional mental health comorbidity, but about 10 percent still have two or more additional mental health diagnoses. Table 8 provides the same comorbidity information for the officer population. Similar to the enlisted population, depression remain the top category of comorbidity, and a substantial share of PTSD officers also suffer from other mental health illness (that are not substance abuse or psychosis). Unlike the enlisted population, substance abuse is not a common comorbidity of PTSD among officers. The count of comorbidity distribution is also similar. Among the inpatient PTSD population, the majority (ranging from two-thirds in Navy to 100 percent in Marines) have at least one comorbidity in addition to PTSD. Among the outpatient PTSD population, between 55 percent (Air Force) to 60 percent (Marines) have a simple case of PTSD with no additional mental health comorbidity. Note that the officer PTSD population is a lot smaller (especially among the inpatient population), and some of the reported distribution is based on very few cases.
Comments
In this study, we link deployment information and TRICARE health records for a random sample of active duty population to examine the relationship between deployment intensity and PTSD. We find that the percentage of PTSD diagnoses among the active duty population varies by service, but are all below one percent among those not deployed on OEF/OIF missions. But, those deployed to Iraq/Afghanistan have a much higher probability of being diagnosed with PTSD, with the percentages ranging from 1.3% for the Air Force to 6.5% for the Navy in the enlisted Army to an odds ratio of 3.54 for the Marines. The tour length also matters for all services in the enlisted population, as a deployment lasting longer than 180 days increases the odds of PTSD by 1.11 times to 2.84 times, depending on the service, compared to a short tour. Furthermore, for the Army and Navy, a deployment to Iraq/Afghanistan further exacerbates the adverse effect of tour length. For the officers population, tour length only appears to matter for Army and Navy, but not for Marines nor Air Force. The sizable adverse effect of deployment location persists when we considered all past deployments, not just the previous deployment.
Our overall rates of PTSD are much lower than previously reported based on surveys or on VA data (Ramchand, et al., 2008) . There are several important factors that contribute to the differences. First, our sample is active duty personnel who are still deemed fit to serve in the military, whereas people who show up in the VA health care system are those who had left the military because they have serious physical or mental health problems that prevent them from continuing to serve. Second, compared to PTSD rates reported in anonymous surveys, which lack clinical details in the screening questions, our PTSD rates are based on clinical diagnoses. Military personnel may be more willing to admit to PTSD symptoms, even if they were mild, on an anonymous survey than they would to military health officials. Third, for people who have the desire to continue serving (and thus stay within the TRICARE system), the stigma of PTSD often prevents them from seeking care when needed since this information would then go on the service person's record.
It is also important to keep in mind the following limitations of this study. First, even though we were able to include military occupational specialty categories, we do not have details on the specific assignments. The lack of details on assignments might contribute to the lower odds ratios we observe among Navy and Air Force personnel who were deployed on OEF/OIF missions that are not in Iraq or Afghanistan. 2 Second, since our intention is to look at the prevalence of PTSD among the population of personnel who are still in service, we most likely miss severe cases of PTSD since those would show up in the VA system unless they were first diagnosed inside the TRICARE system. Lastly, using clinical diagnosis in a system that is not explicitly screening for PTSD has its own shortcoming. For example, using a sample of veterans studied before the VA instituted mandatory screening, Magruder and colleagues found that less than 1 in 5 cases of PTSD were detected among those seen only in primary care setting (Magruder, et al., 2004) . Even though we have complete history of medical encounters during the study period (both inpatient and outpatient records), using clinical diagnoses to identify PTSD population is likely underestimate PTSD's true prevalence among still active population. However, we don't expect the degree of underestimation to differ by the deployment characteristics, therefore the odds ratios we estimated for the effect of deployment intensity on PTSD would not be biased.
With these caveats in mind, there are several important policy implications from our findings. First, the adverse effects of deployment location and duration are much larger in the enlisted population than in the officer population. This is most likely due to the differences in the tasks assigned to the two populations. Such findings do raise the question of whether additional mental health preparation is needed for the enlisted population. Second, while the adverse effects of Iraq/Afghanistan deployments across all services is expected, it might be surprising that such deployments cause the highest PTSD rates for the Navy enlisted personnel. This might be due to many sailors deployed to Iraq or Afghanistan being what the military calls Individual Augmentees (IA), who are those deployed individually or in a small group to assist Army and Marines. The IAs are subject to additional stress as they are thrust into an unfamiliar environment away from their parent command. It may be important to train these personnel for not just the additional physical skills but also mental health readiness for such assignments. In addition, the adverse effect of tour length is observed across all services in the enlisted population-and for the Air Force, longer durations are more likely to lead to PTSD than being deployed in Afghanistan/Iraq. While a recommendation of the optimal tour length for each branch is beyond the scope of this study, our findings do suggest that efforts to keep OEF/OIF deployments to reasonable lengths could help reduce PTSD rates.
Given the continuing nature of the Global War on Terror, it is unavoidable that many still active personnel will be subjected to multiple deployments to OEF/OIF locations. We can expect thousands of new cases of PTSD, and it is imperative to monitor these soldiers' mental health. The 
